Recombinant Human Azurocidin/CAP37/HBP Protein

Newer Version Available: 2200-SE/CF
NEW

Discontinued Product

2200-SE has been discontinued and is replaced by 2200-SE/CF.

R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (3)
FAQs
Reviews

Recombinant Human Azurocidin/CAP37/HBP Protein Summary

Product Specifications

Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to enhance LPS-induced TNF-alpha secretion from human monocytes. Rasmussen, P.B. et al. (1996) FEBS Letters 390:109. The ED50 for this effect is 1.20-12.0 µg/mL.
Source
Mouse myeloma cell line, NS0-derived human Azurocidin/CAP37/HBP protein
Ile27-Pro250, with a C-terminal 10-His tag
Accession #
N-terminal Sequence
Analysis
Ile27
Predicted Molecular Mass
26 kDa
SDS-PAGE
39 kDa, reducing conditions

Product Datasheets

You must select a language.

x

2200-SE (with carrier)

You must select a language.

x

2200-SE/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

2200-SE

Formulation Lyophilized from a 0.2 μm filtered solution in HEPES and NaCl with Trehalose and BSA as a carrier protein.
Reconstitution Reconstitute at 200 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

2200-SE/CF

Formulation Lyophilized from a 0.2 μm filtered solution in HEPES and NaCl with Trehalose.
Reconstitution Reconstitute at 200 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: Azurocidin/CAP37/HBP

Azurocidin, also known as cationic antimicrobial protein 37 (CAP37) and heparin-binding protein (HBP), is a member of the serine protease family that includes Cathepsin G, neutrophil elastase (NE), and proteinase 3 (PR3). These proteases are found in the specialized azurophilic granules of neutrophils (1, 2). Human Azurocidin 1 is encoded by the AZU1 gene located in a cluster with NE and PR3 on chromosome 19pter (2). The open reading frame predicts a 251 amino acid (aa) protein with an N-terminal 26 aa signal sequence and a 7 aa propeptide. There are also eight cysteine residues and 3 putative N-linked glycosylation sites (1).

Although Azurocidin 1 shares a significant degree of aa sequence identity with Cathepsin G, NE, and PR3, it lacks serine protease activity due to mutations at two of the three residues in the catalytic triad (His41Ser and Ser175Gly) (1, 3). Crystallographic analysis suggests that the antibacterial activity of Azurocidin is mediated by a hydrophobic pocket (residues 20 to 44) that binds Gram-negative bacteria lipid A. These structural data also imply that the heparin binding capacity is mediated by non-specific electrostatic interactions between the negatively charged heparin molecule and a large patch of positively charged residues near the lipid A binding site (3).

Azurocidin has also been identified as a modulator of endothelial permeability. Neutrophils arriving first at sites of inflammation release Azurocidin, which acts in a paracrine fashion on endothelial cells causing the development of intercellular gaps and allowing leukocyte extravasation. These findings imply that Azurocidin may be a reasonable therapeutic target for a variety of inflammatory disease conditions (4).

References
  1. Morgan, J.G. et al. (1991) J. Immunol. 147:3210.
  2. Zimmer, M. et al. (1992) Proc. Natl. Acad. Sci. USA 89:8215.
  3. Iverson, L.F. et al. (1997) Nat. Struct. Biol. 4:265.
  4. Gautam, N. et al. (2001) Nat. Med. 7:1123.
Long Name
Azurocidin/Cationic Antimicrobial Protein-37/Heparin Binding Protein
Entrez Gene IDs
566 (Human)
Alternate Names
AZAMP; AZU; AZU1; azurocidin 1; Azurocidin; CAP37; CAP37Heparin-binding protein; cationic antimicrobial protein 37; HBP; HBPCationic antimicrobial protein CAP37; HUMAZUR; NAZC; neutrophil azurocidin

Citations for Recombinant Human Azurocidin/CAP37/HBP Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

3 Citations: Showing 1 - 3
Filter your results:

Filter by:

  1. Heparin-binding protein is important for vascular leak in sepsis
    Authors: Adam Linder
    Intensive Care Med Exp, 2016-10-04;4(1):33.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. Phenol-soluble modulin ?4 mediates Staphylococcus aureus-associated vascular leakage by stimulating heparin-binding protein release from neutrophils
    Sci Rep, 2016-07-07;6(0):29373.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: ELISA (Standard)
  3. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Authors: Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, Prechel M, Prestwich GD, MacArthur RB, Walters BB, Hoidal JR, Kennedy TP
    Am. J. Physiol., Cell Physiol., 2010-04-07;299(1):C97-110.
    Applications: Binding Assay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human Azurocidin/CAP37/HBP Protein

There are currently no reviews for this product. Be the first to review Recombinant Human Azurocidin/CAP37/HBP Protein and earn rewards!

Have you used Recombinant Human Azurocidin/CAP37/HBP Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review